During tumor progression, malignant cells must repeatedly survive microenvironmental stress. Hypoxia-inducible factor-1 (HIF-1) signaling has emerged as one major pathway allowing cellular adaptation to stress. Recent findings led to the hypothesis that HIF-1␣ may enhance the metastatic potential of tumor cells by a survival-independent mechanism. So far it has not been shown that HIF-1␣ also directly regulates invasive processes during metastasis in addition to conferring a survival advantage to metastasizing tumor cells. In a hypoxia-tolerant tumor cell line (L-CI.5s), which did not rely on HIF-1 signaling for viability in vitro and in vivo, knockdown of Hif-1␣ reduced invasiveness of the tumor cells in vitro as well as extravasation and secondary infiltration in vivo. Liver metastases associated induction of proinvasive receptor tyrosine kinase Met phosphorylation as well as gelatinolytic activity were Hif-1␣-dependent. Indeed, promoter activity of the matrix metalloproteinase-9 (mmp-9) was shown to be Hif-1␣-dependent. This study uncovers a new survival-independent biological function of HIF-1␣ contributing to the efficacy of metastases formation.During the metastatic cascade, tumor cells encounter several kinds of microenvironmental stress, namely lack of oxygen and nutrients (1). Hypoxia-inducible factor-1 (HIF-1) 2 is a transcription factor known to mediate the adaptation to microenvironmental stress in general (2) as well as during tumor progression in particular (1). HIF-1 consists of a constitutively expressed -subunit and a highly regulated ␣-subunit that is, under physiological conditions, degraded by the proteasome (3, 4). During stress situations such as hypoxia, HIF-1␣ is stabilized and translocates to the nucleus where it forms together with HIF-1 the heterodimeric transcription factor HIF-1 (5). Via its interaction with hypoxia-responsive elements, HIF-1 regulates the expression of molecules such as the major pH-regulating enzyme carbonic anhydrase IX (CAIX) (6), which allows the metabolic adaptation on the cellular level (7,8). Furthermore, HIF-1 signaling is also a major determinant of adaptation on the tissue level by induction of the "angiogenic switch," thereby overcoming the limited supply of oxygen and nutrients in expanding neoplasias (1).Recent findings led us to the hypothesis that HIF-1␣ not only impacts on metastasis formation by securing survival but also directly impacts on metastasis in a survival-independent manner. This hypothesis was based on the following findings. Reduced levels of HIF-1␣ correlate with decreased invasive potential of tumor cells in vitro (9 -11). HIF-1␣ knock-out reduced primary tumor onset and growth in a transgenic model of cancer initiation (12). This correlated with a later onset of pulmonary metastasis (12). Furthermore, constitutive expression of HIF-1␣ has been shown to enhance bone metastasis in a breast cancer model (13). Although these data have suggested that HIF-1␣ increases the metastatic potential of tumor cells, recent reviews by Bertout et ...